Efficacy and safety of edoxaban in patients with chronic thromboembolic pulmonary hypertension: protocol for a multicentre, randomised, warfarin-controlled, parallel group trial - KABUKI trial.

Kazuya HosokawaKohtaro AbeJunji KishimotoYuko KobayakawaKoji TodakaYuichi TamuraKoichiro TatsumiTakumi InamiNobutaka IkedaYu TaniguchiShun MinatsukiToyoaki MuroharaSatoshi YasudaKeiichi FukudaHiroyuki Tsutsui

Published in: BMJ open (2022)

This paper was written per the study protocol V.4.0, dated 29 January 2021.

Keyphrases

study protocol
randomized controlled trial
clinical trial
pulmonary hypertension
open label
phase iii
double blind
venous thromboembolism
atrial fibrillation
phase ii
placebo controlled
cross sectional